Market Place
Sourcing Support
Merus Hails `Unprecedented` Survival on Solid Tumor Bispecific
24 May 2025 //
PRESS RELEASE
Merus to Present at BofA Securities 2025 Health Care Conference
08 May 2025 //
GLOBENEWSWIRE
Merus Announces Q1 2025 Financial Results and Business Update
07 May 2025 //
GLOBENEWSWIRE
Merus to Present at Upcoming Investor Conferences
25 Feb 2025 //
GLOBENEWSWIRE
Myerus`s Biologic Bizengri Receives Approval in US
04 Dec 2024 //
FDA
Merus cancer bispecific lives up to investors` expectations
24 May 2024 //
FIERCE BIOTECH
Merus Announces Poster Presentations for Zenocutuzumab and MCLA-129
11 Mar 2021 //
GLOBENEWSWIRE
Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell
20 Jan 2021 //
PRNEWSWIRE
Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell
18 Jan 2021 //
PRNEWSWIRE
Merus Announces Collaborations with Nationwide Medical Organizations
12 Jan 2021 //
GLOBENEWSWIRE
Merus Announces Presentation of Phase 1 Clinical Data for MCLA-158
11 Jan 2021 //
GLOBENEWSWIRE
Merus Granted FDA Fast Track Designation of Zenocutuzumab
07 Jan 2021 //
GLOBENEWSWIRE
Merus and Sema4 Enter Into an Agreement to Support Merus’ Ph1/2 Zenocutuzumab
17 Dec 2020 //
GLOBENEWSWIRE
Merus and Sema4 Enter Into an Agreement Merus’ Ph 1/2 Trial of Zenocutuzumab
17 Dec 2020 //
GLOBENEWSWIRE
Merus Announces Poster Presentations on MCLA-145 at Society
09 Nov 2020 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.